People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Syntilla Medical, LLC | — | Healthtech | Seed | $6.0M | $41.4M | 2014 |
| EarlyCell, Inc. | — | Biotechnology | Pre-Seed | $800K | $44.2M | 2015 |
Ken Reed at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ken Reed on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arnon Chait | 1 | 2 |
| Mike Colvin | 1 | 1 |
| Claire Denault | 1 | 1 |
| Corazon Ramirez | 1 | 1 |
| Robert Bulger | 1 | 1 |
| Ted Groesbeck | 1 | 1 |
| Scott Letier | 1 | 1 |
| Kory Razaghi | 1 | 1 |
| P. David Jackson | 1 | 1 |
| Bob Bulger | 1 | 1 |
| Boris Zaslavsky | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.